ArticleAnnals of translational medicine2018

Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.

Lu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.